Tenivac Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The tenivac market research report is one of a series of new reports that provides tenivac market statistics, including the tenivac industry global market size, regional shares, competitors with the tenivac market share, detailed tenivac market segments, market trends, and opportunities, and any further data you may need to thrive in the tenivac industry. This tenivac market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to rising global vaccination demand, increased funding for immunization programs, an aging population requiring vaccination, growing healthcare infrastructure in emerging markets, and expansion of vaccine coverage in low-income countries. Major trends in the forecast period include the adoption of combination vaccines, the development of thermostable and easier-to-administer vaccines, personalized and targeted immunization strategies, preventive health measures post-pandemic, and advancements in vaccine development.

The increasing prevalence of tetanus and diphtheria cases is expected to significantly contribute to the growth of the tenivac market. Tetanus and diphtheria are serious bacterial infections that can lead to severe complications if not properly vaccinated. The rise in cases is linked to factors such as insufficient immunization coverage in certain areas and ongoing environmental and healthcare risks. Tenivac plays a crucial role in preventing these infections by providing long-lasting immunity, which helps manage outbreaks and protect individuals from these potentially fatal diseases. For example, in August 2023, the European Centre for Disease Prevention and Control, a Sweden-based EU agency, reported a total of 281 confirmed cases of diphtheria between January 2022 and August 2023, with 224 cases in 2022 and 57 in 2023, as well as four fatalities. As the prevalence of tetanus and diphtheria continues to rise, the demand for vaccines such as tenivac is expected to increase.

The growing number of government vaccination initiatives is another factor likely to drive the growth of the tenivac market. Government vaccination programs are organized efforts to promote and distribute vaccines to protect populations from infectious diseases. These initiatives are gaining momentum due to concerns over public health, disease prevention, and achieving herd immunity, with backing from government funding, policies, and outreach efforts. Many governments are focusing on comprehensive immunization programs to combat diseases such as tetanus, diphtheria, and pertussis, expanding vaccination coverage through public health campaigns and increasing accessibility for larger populations. For instance, in November 2024, the United Nations Children's Fund (UNICEF) reported that 270,000 doses of the Tetanus-Diphtheria (Td) vaccine were delivered to Ukraine, funded by the government of France. As governments continue to ramp up vaccination efforts, the demand for tenivac is expected to grow.

The global trend of an aging population is also set to drive the expansion of the tenivac market. This demographic shift, which is largely due to longer life expectancies and lower birth rates, results from improvements in healthcare, living standards, and medical technology. As people age, their immune systems become weaker, making them more susceptible to infections. Tenivac helps protect the elderly by boosting their immunity and providing protection against diseases such as tetanus and diphtheria. For example, in July 2024, the House of Commons Library in the UK reported that individuals aged 65 and older accounted for around 19% of the UK’s population in 2022, approximately 12.7 million people. By 2072, this group is projected to increase to 22.1 million, or 27% of the population. As the number of elderly individuals continues to rise, the need for vaccines such as tenivac will likely increase as well.

The key company operating in the tenivac market is Sanofi Pasteur.

North America was the largest region in the tenivac market in 2024. The regions covered in tenivac report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tenivac market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Tenivac is a vaccine designed to protect against tetanus and diphtheria, both of which are serious bacterial infections. This combination vaccine contains inactivated tetanus toxoid and inactivated diphtheria toxoid. Tenivac is commonly administered as a booster vaccine to individuals aged 7 years and older who are at risk for these infections. It is typically given as part of routine immunization schedules or following injuries where there is a concern about tetanus.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary indications for tenivac include diphtheria, tetanus, and pertussis. Diphtheria is a bacterial infection that primarily affects the throat, causing breathing difficulties and potentially leading to severe complications. The vaccine is available through various distribution channels, including direct sales, retail pharmacies, and online pharmacies. It is used by a range of end users, including hospitals, clinics, and ambulatory surgical centers.

The tenivac market consists of sales of Td (Tetanus and Diphtheria) vaccines, DT vaccines, Tdap vaccines, and DTaP vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.